Marsh & McLennan Companies, Inc. (NYSE:MMC - Free Report) - Zacks Research lowered their FY2027 earnings per share estimates for Marsh & McLennan Companies in a research report issued on Thursday, May 1st. Zacks Research analyst R. Department now forecasts that the financial services provider will post earnings per share of $11.29 for the year, down from their prior estimate of $11.31. The consensus estimate for Marsh & McLennan Companies' current full-year earnings is $9.61 per share.
Marsh & McLennan Companies (NYSE:MMC - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The financial services provider reported $3.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.02 by $0.04. Marsh & McLennan Companies had a net margin of 16.60% and a return on equity of 32.60%. The business had revenue of $6.70 billion during the quarter, compared to the consensus estimate of $7.08 billion. During the same quarter last year, the firm posted $2.89 EPS.
MMC has been the subject of a number of other research reports. Jefferies Financial Group lifted their price target on Marsh & McLennan Companies from $237.00 to $244.00 and gave the company a "hold" rating in a research note on Friday, April 11th. Keefe, Bruyette & Woods reduced their target price on shares of Marsh & McLennan Companies from $220.00 to $215.00 and set an "underperform" rating for the company in a research note on Monday, April 21st. Raymond James reissued an "outperform" rating and set a $250.00 target price (up previously from $240.00) on shares of Marsh & McLennan Companies in a research report on Thursday, February 6th. Barclays boosted their price target on shares of Marsh & McLennan Companies from $246.00 to $249.00 and gave the stock an "equal weight" rating in a report on Friday, April 11th. Finally, Redburn Atlantic initiated coverage on Marsh & McLennan Companies in a research report on Tuesday, March 25th. They issued a "buy" rating and a $281.00 target price for the company. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and five have given a buy rating to the stock. According to MarketBeat, Marsh & McLennan Companies presently has a consensus rating of "Hold" and an average price target of $241.93.
Get Our Latest Stock Analysis on MMC
Marsh & McLennan Companies Stock Up 1.4 %
Shares of NYSE MMC opened at $227.21 on Monday. The company has a debt-to-equity ratio of 1.44, a current ratio of 1.13 and a quick ratio of 1.13. Marsh & McLennan Companies has a 1 year low of $199.69 and a 1 year high of $248.00. The stock has a market capitalization of $111.95 billion, a P/E ratio of 27.74, a P/E/G ratio of 2.70 and a beta of 0.85. The company has a 50-day moving average price of $231.01 and a 200-day moving average price of $224.52.
Institutional Investors Weigh In On Marsh & McLennan Companies
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MMC. Financial Life Planners purchased a new position in Marsh & McLennan Companies during the 4th quarter valued at $33,000. Sierra Ocean LLC purchased a new position in shares of Marsh & McLennan Companies during the fourth quarter valued at approximately $36,000. Ameriflex Group Inc. bought a new position in Marsh & McLennan Companies during the 4th quarter valued at approximately $37,000. City Holding Co. purchased a new position in Marsh & McLennan Companies during the first quarter valued at $37,000. Finally, Albion Financial Group UT purchased a new stake in shares of Marsh & McLennan Companies in the fourth quarter worth $38,000. 87.99% of the stock is currently owned by institutional investors.
Insider Activity
In other news, VP Stacy Mills sold 1,317 shares of the firm's stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $234.97, for a total transaction of $309,455.49. Following the transaction, the vice president now directly owns 2,923 shares of the company's stock, valued at approximately $686,817.31. This trade represents a 31.06 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Dean Michael Klisura sold 7,121 shares of the firm's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $234.97, for a total value of $1,673,221.37. Following the transaction, the chief executive officer now owns 20,935 shares in the company, valued at approximately $4,919,096.95. The trade was a 25.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 69,634 shares of company stock worth $16,244,986. 0.35% of the stock is currently owned by insiders.
Marsh & McLennan Companies Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 3rd will be given a $0.815 dividend. The ex-dividend date of this dividend is Thursday, April 3rd. This represents a $3.26 dividend on an annualized basis and a dividend yield of 1.43%. Marsh & McLennan Companies's dividend payout ratio (DPR) is presently 39.95%.
About Marsh & McLennan Companies
(
Get Free Report)
Marsh & McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.